![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.512, 2006-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Azathioprine with phenotype testing best bet in IBD
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mercaptopurine and azathioprine resistance in IBD
Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Perphenazine may be best bet in schizophrenia
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Photoselective vaporisation best bet for BPH
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Perphenazine may be best bet in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 521, 2007-01 ,pp. :